glp1 and glp2 tirzepatide GLP-2 (40mg vials) Pharmacogenomics of Tirzepatide: Genomic Insights

You might consider Wegovy if Youve regained a significant portion of your initial weight loss You didnt achieve the weight loss goals expected from surgery Its been at least 12-18 months since your surgery and weight has stabilised or started increasing Youve already tried lifestyle modifications without sufficient success Your bariatric team agrees its appropriate for your situation Research suggests timing matters One study found that the average time between surgery and starting semaglutide was about 5 years

That connection raised eyebrows since semaglutides are made to "turn off" once blood sugar levels are reduced to a certain "low-normal" point

After accounting for important factors such as age, body mass index (BMI), cancer severity, and other health conditions, the team found that people taking GLP-1 drugs still had a significantly lower risk of death

Furthermore, changes in weight, particularly rapid weight loss, can affect bile composition, increasing the risk of gallstones

Changes in meals, physical activity, body weight, illness, stress, kidney function, or liver function may change insulin requirements

However, its essential to be aware of potential side effects, such as: Stomach discomfort Possible diarrhea Reduced vitamin B12 levels with long-term use Understanding the mechanisms, benefits, and possible side effects of this treatment is crucial for anyone considering it